Cubist Systematic Strategies, LLC Novo Cure LTD Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 251,618 shares of NVCR stock, worth $4.29 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
251,618
Previous 335,218
24.94%
Holding current value
$4.29 Million
Previous $9.99 Million
55.12%
% of portfolio
0.03%
Previous 0.07%
Shares
26 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$192 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$152 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$94.1 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$88.9 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.79B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...